Abstract
Our recent in vivo human studies showed that colonic administration of sodium acetate (SA) resulted in increased circulating acetate levels, which was accompanied by increments in whole-body fat oxidation in overweight-obese men. Since skeletal muscle has a major role in whole-body fat oxidation, we aimed to investigate effects of SA on fat oxidation and underlying mechanisms in human primary skeletal muscle cells (HSkMC). We investigated the dose (0-5 mmol/L) and time (1, 4, 20, and 24 h) effect of SA on complete and incomplete endogenous and exogenous oxidation of C-14-labeled palmitate in HSkMC derived from a lean insulin sensitive male donor. Both physiological (0.1 and 0.25 mmol/L) and supraphysiological (0.5, 1 and 5 mmol/L) concentrations of SA neither increased endogenous nor exogenous fat oxidation over time in HSkMC. In addition, no effect of SA was observed on Thr(172)-AMPK alpha phosphorylation. In conclusion, our previously observed in vivo effects of SA on whole-body fat oxidation in men may not be explained via direct effects on HSkMC fat oxidation. Nevertheless, SA-mediated effects on whole-body fat oxidation may be triggered by other mechanisms including gut-derived hormones or may occur in other metabolically active tissues.
Original language | English |
---|---|
Article number | 659928 |
Number of pages | 9 |
Journal | Frontiers in Endocrinology |
Volume | 12 |
DOIs | |
Publication status | Published - 17 Jun 2021 |
Keywords
- gut metabolite
- acetate
- fat oxidation
- insulin sensitivity (IS)
- metabolic health
- CHAIN FATTY-ACIDS
- GLUCAGON-LIKE PEPTIDE-1
- HEPATIC GLUCOSE-PRODUCTION
- RESISTANT STARCH
- COLONIC FERMENTATION
- APPETITE REGULATION
- ENERGY-EXPENDITURE
- HEALTHY-SUBJECTS
- SODIUM-ACETATE
- ADIPOSE-TISSUE